Unknown

Dataset Information

0

Celecoxib Is Associated With Dystrophic Calcification and Aortic Valve Stenosis.


ABSTRACT: Calcific aortic valve disease is a progressive fibrocalcific process that can only be treated with valve replacement. Cadherin-11 has recently been identified as a potential therapeutic target for calcific aortic valve disease. The already approved drug celecoxib, a cyclooxygenase-2 inhibitor, binds cadherin-11, and was investigated as a therapeutic against calcific aortic valve disease. Unexpectedly, celecoxib treatment led to hallmarks of myofibroblast activation and calcific nodule formation in vitro. Retrospective electronic medical record analysis of celecoxib, ibuprofen, and naproxen revealed a unique association of celecoxib use and aortic stenosis.

SUBMITTER: Bowler MA 

PROVIDER: S-EPMC6488810 | biostudies-other | 2019 Apr

REPOSITORIES: biostudies-other

altmetric image

Publications

Celecoxib Is Associated With Dystrophic Calcification and Aortic Valve Stenosis.

Bowler Meghan A MA   Raddatz Michael A MA   Johnson Camryn L CL   Lindman Brian R BR   Merryman W David WD  

JACC. Basic to translational science 20190222 2


Calcific aortic valve disease is a progressive fibrocalcific process that can only be treated with valve replacement. Cadherin-11 has recently been identified as a potential therapeutic target for calcific aortic valve disease. The already approved drug celecoxib, a cyclooxygenase-2 inhibitor, binds cadherin-11, and was investigated as a therapeutic against calcific aortic valve disease. Unexpectedly, celecoxib treatment led to hallmarks of myofibroblast activation and calcific nodule formation  ...[more]

Similar Datasets

| S-EPMC8390394 | biostudies-literature
| S-EPMC5546080 | biostudies-other
| S-EPMC5739834 | biostudies-literature
| S-EPMC7843559 | biostudies-literature
2016-03-07 | GSE71534 | GEO
2019-10-08 | GSE138531 | GEO
| S-EPMC6494952 | biostudies-literature
| S-EPMC8150250 | biostudies-literature
| S-EPMC7549171 | biostudies-literature